Literature DB >> 29516668

Ethnic differences in insulin secretory function between black African and white European men with early type 2 diabetes.

Cynthia Mohandas1, Riccardo Bonadonna2, Fariba Shojee-Moradie3, Nicola Jackson3, Linda Boselli4, K George M M Alberti1, Janet L Peacock5, A Margot Umpleby3, Stephanie A Amiel1, Louise M Goff1.   

Abstract

AIM: To test the hypothesis that men of black (West) African ethnicity (black African men [BAM]) with early type 2 diabetes (T2D) would have greater insulin secretory deficits compared with white European men (WEM), following prediabetic hypersecretion.
METHODS: In 19 BAM and 15 WEM, matched for age, body mass index and duration of diabetes, we assessed and modelled insulin secretory responses to hyperglycaemia stimulated intravenously (hyperglycaemic clamp) and orally (meal tolerance test).
RESULTS: With similar post-challenge glucose responses, BAM had lower second-phase C-peptide responses to intravenous glucose (BAM 70.6 vs WEM 115.1 nmol/L/min [ratio of geometric mean 0.55, 95% confidence interval {CI} 0.37, 0.83]; P = .006) and to oral glucose (BAM 65.4 vs WEM 88.5 nmol/L/min [mean difference -23.2, 95% CI -40.0, -6.3]; P = .009). Peripheral insulin response in BAM to oral glucose was preserved (BAM 47.4 vs WEM 59.4 nmol/L/min [ratio of geometric mean 0.89, 95% CI 0.59, 1.35]; P = .566), with relative reductions in insulin clearance (BAM 506.2 vs WEM 630.1 mL/m2 BSA/min [mean difference -123.9, 95% CI -270.5, 22.6]; P = .095), associated with enhanced incretin responses (gastric inhibitory polypeptide incremental area under the curve: BAM 46.8 vs WEM 33.9 μg/L/min [mean difference 12.9, 95% CI 2.1, 23.7]; P = .021).
CONCLUSIONS: In early T2D, BAM had significantly lower insulin secretory responses to intravenous and oral stimulation than WEM. Lower insulin clearance, potentially driven by increased incretin responses, may act to preserve peripheral insulin concentrations. Tailoring early management strategies to reflect distinct ethnic-specific pathophysiology may improve outcomes in this high-risk population.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  African; ethnicity; insulin secretion; type 2 diabetes; β cell

Mesh:

Substances:

Year:  2018        PMID: 29516668     DOI: 10.1111/dom.13283

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

1.  Ethnic differences in body composition, sociodemographic characteristics and lifestyle in people with type 2 diabetes mellitus living in Italy.

Authors:  Stefania Toselli; Emanuela Gualdi-Russo; Paolo Mazzuca; Francesco Campa
Journal:  Endocrine       Date:  2019-07-31       Impact factor: 3.633

2.  Increased β-Cell Responsivity Independent of Insulin Sensitivity in Healthy African American Adults.

Authors:  Latif Armiyaw; Camila Sarcone; Andin Fosam; Ranganath Muniyappa
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

3.  Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.

Authors:  Amy E Mendham; Lisa K Micklesfield; Fredrik Karpe; Andre Pascal Kengne; Tinashe Chikowore; Clement N Kufe; Maphoko Masemola; Nigel J Crowther; Shane A Norris; Tommy Olsson; Sölve Elmståhl; Tove Fall; Lars Lind; Julia H Goedecke
Journal:  Diabetologia       Date:  2022-09-17       Impact factor: 10.460

4.  Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat.

Authors:  Oluwatoyosi Bello; Cynthia Mohandas; Fariba Shojee-Moradie; Nicola Jackson; Olah Hakim; K George M M Alberti; Janet L Peacock; A Margot Umpleby; Stephanie A Amiel; Louise M Goff
Journal:  Diabetologia       Date:  2019-02-06       Impact factor: 10.122

5.  Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men.

Authors:  Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Fariba Shojaee-Moradie; Maria Linda Boselli; Geoff Charles-Edwards; Janet Peacock; A Margot Umpleby; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

6.  Exploring the determinants of ethnic differences in insulin clearance between men of Black African and White European ethnicity.

Authors:  Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Maria Linda Boselli; Fariba Shojaee-Moradie; A Margot Umpleby; Janet Peacock; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff
Journal:  Acta Diabetol       Date:  2021-10-18       Impact factor: 4.280

7.  A Systematic Review of Beta Cell Function in Adults of Black African Ethnicity.

Authors:  M Ladwa; O Hakim; S A Amiel; L M Goff
Journal:  J Diabetes Res       Date:  2019-10-20       Impact factor: 4.011

8.  Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Juraj Koska; Daniel S Nuyujukian; Gideon D Bahn; Jin J Zhou; Peter D Reaven
Journal:  Cardiovasc Diabetol       Date:  2021-12-08       Impact factor: 9.951

9.  Loss of ZnT8 function protects against diabetes by enhanced insulin secretion.

Authors:  Om Prakash Dwivedi; Mikko Lehtovirta; Benoit Hastoy; Vikash Chandra; Nicole A J Krentz; Sandra Kleiner; Deepak Jain; Ann-Marie Richard; Fernando Abaitua; Nicola L Beer; Antje Grotz; Rashmi B Prasad; Ola Hansson; Emma Ahlqvist; Ulrika Krus; Isabella Artner; Anu Suoranta; Daniel Gomez; Aris Baras; Benoite Champon; Anthony J Payne; Daniela Moralli; Soren K Thomsen; Philipp Kramer; Ioannis Spiliotis; Reshma Ramracheya; Pauline Chabosseau; Andria Theodoulou; Rebecca Cheung; Martijn van de Bunt; Jason Flannick; Maddalena Trombetta; Enzo Bonora; Claes B Wolheim; Leena Sarelin; Riccardo C Bonadonna; Patrik Rorsman; Benjamin Davies; Julia Brosnan; Mark I McCarthy; Timo Otonkoski; Jens O Lagerstedt; Guy A Rutter; Jesper Gromada; Anna L Gloyn; Tiinamaija Tuomi; Leif Groop
Journal:  Nat Genet       Date:  2019-11-01       Impact factor: 38.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.